ArticlePloS one2026
Psychometric properties of the Thai version of the Illness-Specific Social Support Scale Short Version-8 (ISSS-8) among hematological malignancy patients in the Northeastern region of Thailand: A multicenter study.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Social support, which is an essential aspect influencing health, has resulted in the development of several approaches for assessment in cancer patients. The Illness-Specific Social Support Scale Short Version-8 (ISSS-8) effectively evaluates social support among diverse patient demographics; however, its psychometric validity has yet to be established in Asian cultural contexts. The objectives of this study were to translate and culturally adapt the ISSS-8 for the Thai setting and to assess its psychometric properties in patients with hematological malignancies (HMs). This study employed a convenience sampling method to select patients with HMs undergoing hospitalization at three tertiary institutions in Northeastern Thailand. Psychometric testing was conducted following the translation and cross-cultural adaptation of the ISSS-8 into Thai. A total of 350 patients were recruited. Participants were randomly divided into two groups for exploratory factor analysis (EFA) (n = 200) and confirmatory factor analysis (CFA) (n = 150). The EFA of the eight items yielded a loading from a two-factor model comprising Positive Support and Detrimental Interactions, which explained 82.44% of the variance. Cronbach's alpha (0.80) and item-total correlations (rho = 0.33-0.65) demonstrated acceptable reliability of the ISSS-8, while test-retest reliability was high (ICC = 0.924--0.934). The average variance extracted (AVE) demonstrated convergent validity for all ISSS-8 subscales, with AVEs ranging from 0.76 to 0.80. Moreover, the total ISSS-8 scale demonstrated a statistically significant but weak positive correlation with the Stanford Inventory of Cancer Patient Adjustment (r = 0.244, p < 0.001), while the Detrimental Interactions subscale was significantly and weak negatively correlated with it (r = 0.237, p < 0.001). These findings suggest that the ISSS-8 captures distinct psychosocial and illness-specific relational constructs that differ from coping self-efficacy and psychological adjustment measured by the SICPA. The ISSS-8 is a short, accurate, and valid instrument for measuring social support in Thai patients with HMs. As a result, healthcare professionals can use the ISSS-8 to assess social support in both research and clinical settings. The findings emphasize the necessity of integrating social support evaluation into cancer management and family-centered care, thereby supporting comprehensive and adaptive healthcare delivery in Thailand.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.